2-氯-4-氟苯基乙腈 | 75279-56-0

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯腈系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-4-氟苯基乙腈
• 中文别名: 2-氯-4-氟苯乙腈
• 英文名称: 2-chloro-4-fluorophenylacetonitrile
• 英文别名: 2-chloro-4-fluorobenzeneacetonitrile；2-(2-chloro-4-fluorophenyl)acetonitrile
• CAS: 75279-56-0
• 化学式: C₈H₅ClFN
• mdl: MFCD00236029
• 分子量: 169.586
• InChiKey: GSMCLMKFBYLWRP-UHFFFAOYSA-N

物化性质

• 熔点：
  67-69 °C
• 沸点：
  253.2±25.0 °C(Predicted)
• 密度：
  1.3099 (estimate)
• 稳定性/保质期：
  远离氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 危险品运输编号：
  3276
• 海关编码：
  2926909090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P280,P305+P351+P338,P311
• 危险性描述：
  H301,H311,H315,H319,H332
• 储存条件：
  存放在密封容器中，并置于阴凉、干燥处。储存地点需远离氧化剂，并且须上锁，钥匙应由技术专家及其助手保管。

SDS

Name:	2-Chloro-4-Fluorobenzylcyanide 99+% Material Safety Data Sheet
Synonym:	None Known
CAS:	75279-56-0

Section 1 - Chemical Product MSDS Name:2-Chloro-4-Fluorobenzylcyanide 99+% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
75279-56-0	2-Chloro-4-Fluorobenzylcyanide	99+	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 75279-56-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H5ClFN
Molecular Weight: 169.59

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 75279-56-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chloro-4-Fluorobenzylcyanide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 75279-56-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 75279-56-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 75279-56-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氯-4-氟苯基乙腈 在 sodium methylate 、 sodium acetate 作用下， 以 乙醇 、 乙酸乙酯 、 甲苯 为溶剂， 反应 13.0h， 生成 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine
  参考文献：
  名称：

  [EN] FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES
  [FR] PYRAZOLES FONGICIDES SUBSTITUÉS PAR NITROANILINO

  摘要：

  本文披露了一种公式1的化合物，包括所有几何和立体异构体、互变异构体、N 氧化物及其盐，其中R1、R2、R3、R4、R5、R6、m和n如披露中定义。还披露了含有公式1化合物的组合物以及用于控制由真菌病原体引起的植物疾病的方法，包括施加本发明的化合物或组合物的有效量。

  公开号：

  WO2020051402A1
• 作为产物：
  描述：

  potassium cyanide 、 2-氯-4-氟溴苄 在 四丁基溴化铵 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 4.0h， 以90%的产率得到2-氯-4-氟苯基乙腈
  参考文献：
  名称：

  KR2017/43091

  摘要：

  公开号：

文献信息

• Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood–Brain Barrier Penetration
  作者：Xin Li、Zhigao Zhang、Yang Chen、Hong Wan、Jiakang Sun、Bin Wang、Bingqiang Feng、Bing Hu、Xingxing Shi、Jun Feng、Lei Zhang、Feng He、Chang Bai、Lianshan Zhang、Weikang Tao

  DOI：10.1021/acsmedchemlett.9b00186

  日期：2019.6.13

  oxytocin receptor (OTR) plays a major role in the control of male sexual responses. Antagonists of the OTR have been reported to inhibit ejaculation in animal models and serve as a potential treatment for premature ejaculation (PE). Herein, we describe a novel scaffold featuring an aryl substituted 3-azabicyclo [3.1.0] hexane structure. The lead compound, SHR1653, was shown to be a highly potent OTR antagonist

  催产素受体（OTR）在控制男性性反应中起主要作用。据报道，在动物模型中，OTR的拮抗剂可抑制射精，并可作为早泄（PE）的潜在治疗方法。在这里，我们描述了一种新型的脚手架，其特征是芳基取代的3-氮杂双环[3.1.0]己烷结构。铅化合物SHR1653被证明是一种高效的OTR拮抗剂，相对于V 1A R，V 1B R和V 2 R表现出优异的选择性。该新型分子也显示出对整个物种都具有良好的药代动力学特征体内一样健壮在大鼠子宫收缩模型中的功效。有趣的是，SHR1653表现出出色的血脑屏障穿透性，可能对中枢神经系统相关PE的治疗有益。
• GLUCOCORTICOID RECEPTOR ANTAGONISTS
  申请人：Bailly Jacques

  公开号：US20090088425A1

  公开（公告）日：2009-04-02

  The present invention relates to compounds of formula I wherein A, n, R 1a to R 1e and R 2 to R 5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are glucocorticoid receptor antagonists useful for the treatment and/or prevention of diseases such as diabetes, dyslipidemia, obesity, hypertension, cardiovascular diseases, adrenal imbalance or depression.

  本发明涉及以下式I的化合物 其中A，n，R1a至R1e和R2至R5如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物是糖皮质激素受体拮抗剂，可用于治疗和/或预防疾病，如糖尿病，血脂异常，肥胖，高血压，心血管疾病，肾上腺失调或抑郁症。
• A generic approach for the catalytic reduction of nitriles
  作者：Stephen Caddick、Duncan B Judd、Alexandra K.de K Lewis、Melanie T Reich、Meredith R.V Williams

  DOI：10.1016/s0040-4020(03)00858-5

  日期：2003.7

  The scope of nickel boride mediated reduction of nitriles has been extended further to allow the preparation of Boc protected amines via a mild catalytic process. It is noteworthy that the toxicity of this procedure is greatly reduced due to its catalytic nature in nickel(II) chloride used in combination with excess sodium borohydride. The protocol is marked by its resilience towards air and moisture

  硼化镍介导的腈还原的范围进一步扩大，以允许通过温和的催化过程制备Boc保护的胺。值得注意的是，由于该方法在与过量的硼氢化钠组合使用的氯化镍（II）中的催化性质，因此大大降低了该方法的毒性。该协议以其对空气和湿气的适应性而著称，因此是一种简单而通用的实用协议。
• FUNGICIDAL SUBSTITUTED AZOLES
  申请人：Selby Thomas Paul

  公开号：US20110045101A1

  公开（公告）日：2011-02-24

  Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein J is Q 2 or R 1 ; X is N, CR 2 or CQ 3 ; Y is N or CR 3 ; Z is N or CR 4 ; and Q 1 , Q 2 , Q 3 , R 1 R 2 and R 3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  揭示了公式1的化合物，包括所有的几何和立体异构体，N-氧化物和盐，其中J是Q2或R1；X是N，CR2或CQ3；Y是N或CR3；Z是N或CR4；Q1，Q2，Q3，R1，R2和R3如披露中定义的。还披露了含有公式1化合物的组合物以及控制由真菌病原体引起的植物疾病的方法，包括施用本发明的化合物或组合物的有效量。
• Compounds for the treatment of diseases
  申请人：Brown Daniel Alan

  公开号：US20050222128A1

  公开（公告）日：2005-10-06

  The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

  本发明涉及公式（1）的化合物，以及用于制备、用于制备的中间体、含有和使用这些衍生物的组合物的过程。根据本发明的化合物在许多疾病、紊乱和状况中具有用途，特别是在炎症性、过敏性和呼吸道疾病、紊乱和状况中。

表征谱图